Reducing Pharmaceutical Tariffs to Invigorate Indonesia’s Economy
The COVID-19 pandemic has demonstrated the important roles both innovation and international trade play in addressing public health concerns. Global collaboration and trade cooperation is essential to delivering breakthrough medicines. Trade barriers, such as high tariffs, make addressing public health concerns more costly for patients. Tariffs are essentially taxes that are levied when a product enters the country.
Strengthening Indonesia’s Economy Through Investments in Health Systems
Investing in health care has immense benefits to local patients and the economy. In fact, for every $1 invested in improving health systems in developing economies, countries can expect an economic return of $2-$4, resulting in a healthier population and higher productivity.
COVID-19 Clinical Development Advancements in Southeast Asia
Clinical trials are a critical phase in the development of any new medicine. They are vital to determining the impact the treatment may have on patients. Since the beginning of the COVID-19 pandemic, clinical researchers throughout Southeast Asia have been working rapidly to test investigational medicines and identify possible vaccine candidates that may treat patients and prevent further spread of the virus.
World Bank, IMF step up support for Southeast Asia’s health systems
Health systems in many low- and middle-income countries across Asia, the Middle East, Africa and Latin America are strained as they cope with the COVID-19 pandemic. Many nations lack the medical staff, equipment and capacities necessary to mitigate the crisis. While governments and corporations are partnering to strengthen health systems, multinational organizations are also stepping in with financial support.